Trademark Overview
On Monday, March 10, 2025, a trademark application was filed for AMBIMUNE with the United States Patent and Trademark Office. The USPTO has given the AMBIMUNE trademark a serial number of 99075663. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 10, 2025. This trademark is owned by ImmunityBio, Inc.. The AMBIMUNE trademark is filed in the Pharmaceutical Products category with the following description:
Medicinal preparations for the treatment and prevention of cancer and infectious diseases; Biological preparations for the treatment of cancer and infectious diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer; Vaccines